These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27183454)

  • 1. Effect of training general practitioners in drug treatment of newly detected heart failure patients with reduced or preserved ejection fraction: A cluster randomized trial.
    van Riet EE; Hoes AW; Limburg A; Landman MA; Zuithoff PN; Rutten FH
    Int J Cardiol; 2016 Aug; 217():174-82. PubMed ID: 27183454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trial.
    van Riet EE; Hoes AW; Limburg A; van der Hoeven H; Landman MA; Rutten FH
    BMC Cardiovasc Disord; 2014 Jan; 14():1. PubMed ID: 24400643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
    Fukuta H; Goto T; Wakami K; Ohte N
    Eur J Prev Cardiol; 2016 Jan; 23(1):78-85. PubMed ID: 25520380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale, design and baseline results of the Treatment Optimisation in Primary care of Heart failure in the Utrecht region (TOPHU) study: a cluster randomised controlled trial.
    Valk MJ; Hoes AW; Mosterd A; Landman MA; Broekhuizen BD; Rutten FH
    BMC Fam Pract; 2015 Oct; 16():130. PubMed ID: 26446696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerobic Interval Training Elicits Different Hemodynamic Adaptations Between Heart Failure Patients with Preserved and Reduced Ejection Fraction.
    Fu TC; Yang NI; Wang CH; Cherng WJ; Chou SL; Pan TL; Wang JS
    Am J Phys Med Rehabil; 2016 Jan; 95(1):15-27. PubMed ID: 26053189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Training general practitioners to improve evidence-based drug treatment of patients with heart failure: a cluster randomised controlled trial.
    Valk MJM; Hoes AW; Mosterd A; Landman MA; Zuithoff NPA; Broekhuizen BDL; Rutten FH
    Neth Heart J; 2020 Nov; 28(11):604-612. PubMed ID: 32997300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
    Shah SJ; Voors AA; McMurray JJV; Kitzman DW; Viethen T; Bomfim Wirtz A; Huang E; Pap AF; Solomon SD
    JAMA; 2019 Jun; 321(21):2101-2112. PubMed ID: 31162568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.
    Maisel AS; Shah KS; Barnard D; Jaski B; Frivold G; Marais J; Azer M; Miyamoto MI; Lombardo D; Kelsay D; Iqbal N; Taub PR; Kupfer K; Lee E; Clopton P; Zile M; Greenberg B
    J Card Fail; 2016 Apr; 22(4):283-93. PubMed ID: 26433086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
    Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
    J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
    Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP;
    Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial.
    Ambrosy AP; Cerbin LP; DeVore AD; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Wojdyla D; Wu A; Mentz RJ
    Am Heart J; 2017 Apr; 186():130-138. PubMed ID: 28454828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).
    Marui A; Nishiwaki N; Komiya T; Hanyu M; Tanaka S; Kimura T; Sakata R;
    Am J Cardiol; 2015 Aug; 116(4):580-6. PubMed ID: 26092271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
    Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
    Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a 6-month pedometer-based walking intervention on functional capacity in patients with chronic heart failure with reduced (HFrEF) and with preserved (HFpEF) ejection fraction: study protocol for two multicenter randomized controlled trials.
    Vetrovsky T; Siranec M; Parenica J; Griva M; Stastny J; Precek J; Pelouch R; Bunc V; Linhart A; Belohlavek J
    J Transl Med; 2017 Jul; 15(1):153. PubMed ID: 28673328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How are patients with heart failure treated in primary care?
.
    Vaillant-Roussel H; Pereira B; Gibot-Boeuf S; Eschalier R; Dubray C; Boussageon R; Vorilhon P
    Int J Clin Pharmacol Ther; 2018 Aug; 56(8):347-357. PubMed ID: 29792395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and Design of the VITALITY-HFpEF Trial.
    Butler J; Lam CSP; Anstrom KJ; Ezekowitz J; Hernandez AF; O'Connor CM; Pieske B; Ponikowski P; Shah SJ; Solomon SD; Voors AA; Wu Y; Carvalho F; Bamber L; Blaustein RO; Roessig L; Armstrong PW
    Circ Heart Fail; 2019 May; 12(5):e005998. PubMed ID: 31096775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.